Statin-boosted cellular uptake of penetratin due to reduced membrane dipole potential

Published: Aug. 5, 2020, 12:01 a.m.

Link to bioRxiv paper: http://biorxiv.org/cgi/content/short/2020.08.04.236984v1?rss=1 Authors: Batta, G., Karpati, L., Fulaneto, G., Tarapcsak, S., Kovacs, T., Zakany, F., Mandity, I. M., Nagy, P. Abstract: Since cell penetrating peptides are promising tools for delivery of cargo into cells, factors limiting or facilitating their cellular uptake are intensely studied. Using labeling with pH-insensitive and pH-sensitive dyes we report that escape of penetratin from acidic endo-lysosomal compartments is retarded compared to its cellular uptake. The membrane dipole potential, known to alter transmembrane transport of charged molecules, is shown to be negatively correlated with the concentration of penetratin in the cytoplasmic compartment. Treatment of cells with therapeutically relevant concentrations of atorvastatin, an inhibitor of HMG-CoA reductase and cholesterol synthesis, significantly increased the release of penetratin from acidic endocytic compartments in two different cell types. This effect of atorvastatin correlated with its ability to decrease the membrane dipole potential. These results highlight the importance of the dipole potential in regulating cellular uptake of cell penetrating peptides and suggest a clinically relevant way of boosting this process. Copy rights belong to original authors. Visit the link for more info